Edition:
United Kingdom

Spectrum Pharmaceuticals Inc (SPPI.OQ)

SPPI.OQ on NASDAQ Stock Exchange Global Select Market

22.97USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$22.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
521,553
52-wk High
$24.18
52-wk Low
$9.03

Chart for

About

Spectrum Pharmaceuticals, Inc. is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has a product portfolio consisting of both commercial stage and development stage products that address various cancer types. The Company has six approved... (more)

Overall

Beta: 1.56
Market Cap(Mil.): $1,341.42
Shares Outstanding(Mil.): 93.94
Dividend: --
Yield (%): --

Financials

  SPPI.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.99 -- --
ROI: -22.34 1.78 14.61
ROE: -36.04 3.28 16.33

BRIEF-Spectrum Pharmaceuticals Reports Q1 Non-GAAP Loss Per Share $0.15

* SPECTRUM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PIPELINE UPDATE

03 May 2018

BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific

* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC

01 May 2018

BRIEF-Shrotriya May Sell Up To 1 Mln Shares Of Spectrum Pharmaceuticals' Common Stock

* RAJESH C. SHROTRIYA - SHROTRIYA MAY SELL UP TO 1 MILLION SHARES OF SPECTRUM PHARMACEUTICALS' COMMON STOCK BETWEEN MARCH 26 AND JUNE 29 - SEC FILING‍​ Source text: (https://bit.ly/2pKokJc) Further company coverage:

27 Mar 2018

BRIEF-Spectrum Pharma Q4 Loss Per Share $0.29

* SPECTRUM PHARMACEUTICALS REPORTS FOURTH QUARTER 2017 AND FULL YEAR 2017 FINANCIAL RESULTS AND PIPELINE UPDATE

06 Mar 2018

BRIEF-Spectrum Pharmaceuticals Announces Appointment Of William Ashton To Its Board

* SPECTRUM PHARMACEUTICALS ANNOUNCES APPOINTMENT OF WILLIAM L. ASHTON TO ITS BOARD OF DIRECTORS

27 Feb 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $129.50 --
Pfizer Inc. (PFE.N) $40.71 --
Novartis AG (NOVN.S) CHF80.90 -0.62
Merck & Co., Inc. (MRK.N) $66.46 --
Roche Holding Ltd. (ROG.S) CHF238.45 -1.05
Roche Holding Ltd. (RO.S) CHF242.40 -0.60
Abbott Laboratories (ABT.N) $63.63 --
Bayer AG (BAYGn.DE) €80.86 -2.90
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.61 -0.24

Earnings vs. Estimates